基本信息
views: 41
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Arnaud Tarantola grew up in Africa and Asia. He trained as a medical doctor in Paris, France and worked for several years in the study and prevention of occupational infections in French and African hospitals. He joined the InVS's international department in 2003, with a focus on early warning systems incl. in the Balkans, Africa and Latin America and contributing to France’s epidemic intelligence system.
From February 2011 to August 2016, Arnaud Tarantola was Head of the Epidemiology and Public Health Department at the Institut Pasteur du Cambodge in Phnom Penh, Cambodia. The unit is a recognized center for field/clinical epidemiology and research in Asia and provides expertise to national authorities. Arnaud Tarantola was a member of the Scientific Advisory Board of the Institut Pasteur International Network's Defeat Dengue program and of WHO's Strategic Advisory Group of Experts (SAGE) Working Group on rabies vaccines and rabies immunoglobulins.
From September 1st, 2016 to August 30, 2019, Arnaud Tarantola headed the Epidemiology unit of the Institut Pasteur in Nouméa, New Caledonia. His mandate was to implement research in and outside of the clinical setting relevant to New Caledonians, focusing on infectious diseases but also microbiome, genomics and host-pathogens response.
From Sept. 2nd, 2019, to Dec. 31st, 2020, A. Tarantola was a Medical Epidemiologist and Researcher at the Lyssavirus Epidemiology and Neuropathology unit and WHO Collaborating Centre for Research on Rabies, Global Health Department, Institut Pasteur, Paris, France.
Since Jan 4, 2021, Arnaud Tarantola is the Head of Santé Publique France's Regional epidemiology unit for Paris and neighbouring Départements. He is involved in Covid-19 surveillance as well as surveillance system preparedness in view of the 2024 Paris Olympics & Paralympics, among other.
A. Tarantola received a MSc in epidemiology in 2003 (LSHTM), a PhD in Epidemiology in September 2018 (Paris Sorbonne-Cité) and a HDR (habilitation to direct research) in 2019.
Contact: arnaud.tarantola@santepubliquefrance.fr
Research Interests
Papers共 172 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Infectious diseases nowno. 4S (2024): 104889-104889
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseasesno. 8 (2024): 1061-1066
Laura Reques, Lilas Mercuriali,Yassoungo Silue,Emilie Chazelle,Guillaume Spaccaferri,Annie Velter,Alexandra Mailles,Pierre Frange,Arnaud Tarantola
EUROSURVEILLANCEno. 21 (2024)
Jeremy Zeggagh,Olivier Ferraris,Maud Salmona,Arnaud Tarantola, Jean-Michel Molina,Constance Delaugerre
Catarina Krug,Arnaud Tarantola,Emilie Chazelle,Erica Fougère,Annie Velter,Anne Guinard,Yvan Souares, Anna Mercier, Céline François, Katia Hamdad, Laetitia Tan-Lhernould, Anita Balestier,
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletinno. 50 (2023)
Aisling M Vaughan,Orlando Cenciarelli,Soledad Colombe,Luís Alves de Sousa,Natalie Fischer,Celine M Gossner,Jeff Pires,Giuditta Scardina,Gudrun Aspelund, Margarita Avercenko, Sara Bengtsson,Paula Blomquist,
Médecine et Maladies Infectieuses Formationno. 2 (2022): S94-S95
Patrick Blanco,Anne Rachline,Arnaud Tarantola,Antoine Biron,Sabine Pereyre,Julie Coutherut, Marion Patoureau
The Lancet. Global healthno. 7 (2022): e989-e1002
Load More
Author Statistics
#Papers: 172
#Citation: 4511
H-Index: 34
G-Index: 59
Sociability: 7
Diversity: 3
Activity: 18
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn